Palo Alto Networks delivered its Q3 results on May 20, and the Street's immediate verdict is a target-price stampede upward — but the options market spent the session hedging harder than it has in months.
The analyst reaction has been swift and one-directional. Morgan Stanley raised its target to $253 from $223 this morning, maintaining Overweight. Stifel moved its target all the way to $275 from $185. Truist lifted to $275 from $200. Earlier in the week Oppenheimer had already pushed to $275, and Wells Fargo and Barclays both raised targets last week ahead of the print. Every move in the past ten days has been a raise, with no analyst cutting or downgrading. The consensus mean target now runs near $222 — materially below the current $240 price — but that aggregate trails the wave of post-earnings revisions still working through the system, and the most recent bellwether raises sit firmly above where the stock trades today.
Options positioning tells a more cautious story than the target-price upgrades might suggest. The put/call ratio jumped to 1.02 on Tuesday — more than 2.5 standard deviations above its 20-day average of 0.93 — making it the most defensive reading in options flow in months. That's a notable pivot from the pre-earnings setup described in Monday's note, when the PCR sat at 0.94 with a barely-there z-score of 0.62 and calls dominated the tape. The flip to elevated put demand on earnings day, even as analysts pile on upgrades, points to investors buying downside insurance on a stock that rose 50% in a single month heading into the print.
Short interest is rebuilding modestly but remains far from threatening. Bears hold roughly 3.9% of the free float — almost unchanged from the pre-earnings level — with the position up around 7% over the past week after weeks of shorts trimming exposure. Cost to borrow remains negligible at 0.43%, and lending availability is extremely loose at over 1,300% of short interest, meaning there is abundant supply for anyone wanting to build a short position. The short score of 36.7 reflects no particular squeeze pressure or extreme conviction from either side in the borrow market.
The February earnings reaction is worth flagging as context. The last time PANW reported, the stock fell 8.7% the next day and extended the slide to -15% over five sessions. That print followed a similarly elevated run-up. The factor picture is mixed: forward EPS growth expectations rank in the 96th percentile across the universe, a genuinely extreme reading, while value scores remain stretched — the P/E multiple has expanded roughly 18 points over the past 30 days alone to sit above 63x. CEO Nikesh Arora's late-March open-market purchase of nearly $10 million of stock at $147 now sits deeply in the money, a data point bulls will note; the subsequent insider selling from the CFO and accounting officer in April at $157-$163 was smaller and routine in character.
Cybersecurity peers had a strong week alongside PANW. ZS led the group with a 19.9% weekly gain, CRWD added 12.9%, and FTNT rose 12.1%. PANW's own 11.4% weekly gain was solid but landed in the middle of the peer pack — noteworthy given it was the one reporting. The day-after pullback of 3% while peers like DDOG gained 3% and FTNT added 0.9% suggests some post-earnings sell-the-news pressure specific to PANW rather than sector rotation.
What to watch next: the June 2 next earnings flag in the data appears to be an error or placeholder given PANW just reported — the more immediate focus will be whether the PCR normalises back below its 20-day mean as hedges roll off, and whether the wave of post-earnings analyst target revisions pulls the consensus mean toward the $253-$275 range where the most recent upgrades now cluster.
See the live data behind this article on ORTEX.
Open PANW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
